We are live on ! Find out more
EOLS icon

Evolus

164 hedge funds and large institutions have $573M invested in Evolus in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 49 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,044% more call options, than puts

Call options by funds: $972K | Put options by funds: $85K

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

12% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 49

2.28% more ownership

Funds ownership: 79.72%82% (+2.3%)

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

1% less funds holding

Funds holding: 165164 (-1)

30% less capital invested

Capital invested by funds: $815M → $573M (-$241M)

Holders
164
Holders Change
-1
Holders Change %
-0.61%
% of All Funds
2.16%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.09%
New
26
Increased
55
Reduced
49
Closed
25
Calls
$972K
Puts
$85K
Net Calls
+$887K
Net Calls Change
-$813K
Name Holding Trade Value Shares
Change
Change in
Stake
AC
26
AWH Capital
Texas
$7.01M -$316K -22,500 -3%
Northern Trust
27
Northern Trust
Illinois
$5.86M +$638K +45,384 +9%
Lord, Abbett & Co
28
Lord, Abbett & Co
New Jersey
$5.5M -$7M -497,600 -50%
Assenagon Asset Management
29
Assenagon Asset Management
Luxembourg
$4.81M -$7.31M -520,102 -54%
AI
30
Allostery Investments
Connecticut
$4.76M +$6.06M +431,117 New
Charles Schwab
31
Charles Schwab
California
$4.65M +$40.9K +2,905 +0.7%
ZP
32
Zimmer Partners
New York
$4.6M +$2.34M +166,500 +67%
Goldman Sachs
33
Goldman Sachs
New York
$4.59M +$1.48M +105,095 +34%
EP
34
Eversept Partners
New York
$4.23M -$985K -70,016 -15%
IC
35
Ikarian Capital
Texas
$4.12M +$1.62M +114,986 +45%
Alyeska Investment Group
36
Alyeska Investment Group
Illinois
$3.59M
Deutsche Bank
37
Deutsche Bank
Germany
$3.4M -$3.34M -237,820 -44%
Walleye Capital
38
Walleye Capital
New York
$3.01M +$844K +60,039 +28%
FCM
39
Frontier Capital Management
Massachusetts
$2.65M +$3.37M +239,811 New
Stifel Financial
40
Stifel Financial
Missouri
$2.18M +$755K +53,673 +37%
EIM
41
Essex Investment Management
Massachusetts
$2.01M -$1.59M -113,050 -38%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$1.92M -$691K -49,169 -22%
TI
43
Trexquant Investment
Connecticut
$1.81M -$1.18M -83,623 -34%
Wellington Management Group
44
Wellington Management Group
Massachusetts
$1.79M -$180K -12,800 -7%
Bank of America
45
Bank of America
North Carolina
$1.75M +$133K +9,440 +6%
AQR Capital Management
46
AQR Capital Management
Connecticut
$1.73M +$105K +7,482 +5%
CM
47
CM Management
Florida
$1.66M
JP Morgan Chase
48
JP Morgan Chase
New York
$1.53M -$447K -31,777 -19%
Bank of New York Mellon
49
Bank of New York Mellon
New York
$1.51M +$183 +13 +0%
UBS AM
50
UBS AM
Illinois
$1.27M +$95.9K +6,821 +6%

EOLS Hedge Fund Activity: Q4 2024 in Review

164 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q4 2024, worth a combined $573M — down 30% from $815M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new EOLS positions and 25 closed out — a net gain of 1 holder — while 55 added to existing stakes and 49 trimmed.

The largest buyer was Tri Locum Partners, opening a new position worth an estimated $10.4M. The largest seller was Assenagon Asset Management, cutting an estimated $7.31M.

  • 164 institutional investors held Evolus (EOLS) as of Q4 2024, down from 165 in Q3 2024.
  • Funds reported $573M of Evolus stock for Q4 2024, down 30% quarter-over-quarter.
  • 26 funds opened new Evolus positions in Q4 2024 and 25 closed out, a net change of +1 holder.
  • The largest Evolus buyer in Q4 2024 was Tri Locum Partners, an estimated $10.4M added.
  • The largest Evolus seller in Q4 2024 was Assenagon Asset Management, an estimated $7.31M sold.

Based on aggregated 13F filings for Q4 2024.